LOM Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113K Buy
720
+245
+52% +$36.7K 0.03% 185
2026
Q1
$72.6K Hold
475
0.02% 191
2025
Q4
$65.5K Hold
475
0.02% 195
2025
Q3
$61K Buy
+475
New +$58K 0.02% 182

Other funds holding NVS

LOM Asset Management's NVS Position: Q2 2026 in Review

LOM Asset Management increased its Novartis (NVS) stake by 52% in Q2 2026, buying an estimated $36.7K and bringing the position to 720 shares worth $113K. The position accounts for 0.03% of the portfolio, ranked #185.

LOM Asset Management first reported a position in NVS in Q3 2025 and has held it in 4 quarters since. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • LOM Asset Management held 720 shares of Novartis worth $113K as of Q2 2026.
  • LOM Asset Management bought 245 Novartis shares in Q2 2026, an estimated $36.7K.
  • Novartis made up 0.03% of LOM Asset Management's portfolio in Q2 2026, its #185 holding.
  • LOM Asset Management first reported a position in Novartis in Q3 2025 and has held it in 4 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on LOM Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.